Fat metabolism and weight
10Component-level evidence; not evidence for this blend.
Weight managementBlend
Fat Blaster
Nonstandard lipotropic nutrient blend
Community reportsWeight management · energy1
Investigational or nonstandard product; no FDA-approved formulation verified for this exact entry.
What does it do?
Variable lipotropic blend containing carnitine, MIC, B vitamins and NADH. This specific combination has no demonstrated clinical weight-loss efficacy.
Approved & studied uses
No established medical use is documented for this formulation.
Community uses Reported, unvalidated
Insulin sensitivity
10Inositol/B6 findings cannot establish whole-formula effects.
Liver health
10Choline and methionine roles; 'detox' claims are not clinical outcomes.
Energy and methylation
10Benefits may depend on deficiency.
Reasons people report using it; these do not establish benefit.10
Evidence limits
View research →No validated combined-product PK, interactions or clinical response timeline.1
0 distinct primary sources or abstracts checked. Evidence may concern a parent compound, individual blend ingredient, animal, or cell model; it does not necessarily establish a benefit for this exact product.
Evidence definitions →Key safety information
All risks →Human safety is unresolved
The checked material does not establish a human adverse-event rate or safe self-use regimen for this exact product.1
Investigational or nonstandard product; no FDA-approved formulation verified for this exact entry.
Molecular information
Amino-acid sequence
This blend contains multiple compounds and has no single amino-acid sequence.
Multiple componentsComposition varies
LengthNot a single peptide
Molecular weight · DaNo single molecular weight
Formula, sequence notation & identity
Molecular formulaNo single formula1
Nonstandard lipotropic nutrient blend
Ingredient identities and quantities vary by formulation.
Pharmacokinetics
How long does it stay in the body?
What to expect
Study outcomes
Ingredient evidence does not test the blend
The listed bibliography concerns individual nutrients, other formulations or broad nutrition research. No controlled study of this exact named injectable combination was identified in the targeted search.1
Community poll 10 topics · Pep-Pedia snapshot
Voluntary, unverified reports. These percentages do not measure effectiveness or safety.
Experience
Number of responses to this question: not disclosed.
Duration of use
Number of responses to this question: not disclosed.
Age range
Number of responses to this question: not disclosed.
Gender
Number of responses to this question: not disclosed.
Primary goal
Number of responses to this question: not disclosed.
Effectiveness
The source hides 1 additional categories. Their labels and percentages are unavailable.
Number of responses to this question: not disclosed.
Side effects
Number of responses to this question: not disclosed.
Dosage frequency
Number of responses to this question: not disclosed.
Would recommend
Number of responses to this question: not disclosed.
How discovered
The source hides 1 additional categories. Their labels and percentages are unavailable.
Number of responses to this question: not disclosed.
Source & limitations
The source displays “314 responses” for this profile. This is not a confirmed participant count or a denominator for individual questions.
- Voluntary self-reports from Pep-Pedia visitors; identity, treatment, outcomes and timing are unverified. These data are not efficacy or safety estimates.
- The source displays a profile-wide response label, not a confirmed unique participant count. It stays unchanged across questions. Question-specific denominators and absolute option counts are not exposed.
- Only the top five categories are displayed for some questions. Extra categories are retained as an undisplayed-category count; their labels and percentages are unavailable.
- Displayed percentages are rounded. They may not total 100%, especially where categories are hidden.
- This is a dated snapshot, not a live survey or current recommendation.
Protocols
Doses & schedules
Compare purpose, amount, route, frequency, and duration.
Source corrections
No standardized formula or validated combination timeline; interaction classifications are source claims.
Route
Scroll to compare all columns →
| Route | Dose | Frequency | Goal / evidence | Duration | References |
|---|---|---|---|---|---|
| SubQSubcutaneous | 1 mL (per vendor formulation) | 1-2x weekly | General metabolic supportReference report | 4-12 weeks typical program length | 10 |
Population Population not independently verified; see the reference and linked research. Context Reported in Pep-Pedia’s educational protocol table. Study attribution and applicability to this exact product are not independently established. No standardized formula or validated combination timeline; interaction classifications are source claims. Source route wording IM or SubQ Source tabs Injectable | |||||
| IMIntramuscular | 1 mL (per vendor formulation) | 1-2x weekly | General metabolic supportReference report | 4-12 weeks typical program length | 10 |
Population Population not independently verified; see the reference and linked research. Context Reported in Pep-Pedia’s educational protocol table. Study attribution and applicability to this exact product are not independently established. No standardized formula or validated combination timeline; interaction classifications are source claims. Source route wording IM or SubQ Source tabs Injectable | |||||
| SubQSubcutaneous | 1 mL | 2-3x weekly | Weight management programReference report | 4-12 weeks typical program length | 10 |
Population Population not independently verified; see the reference and linked research. Context Reported in Pep-Pedia’s educational protocol table. Study attribution and applicability to this exact product are not independently established. No standardized formula or validated combination timeline; interaction classifications are source claims. Source route wording IM (clinic) or SubQ (home) Source tabs Injectable | |||||
| IMIntramuscular | 1 mL | 2-3x weekly | Weight management programReference report | 4-12 weeks typical program length | 10 |
Population Population not independently verified; see the reference and linked research. Context Reported in Pep-Pedia’s educational protocol table. Study attribution and applicability to this exact product are not independently established. No standardized formula or validated combination timeline; interaction classifications are source claims. Source route wording IM (clinic) or SubQ (home) Source tabs Injectable | |||||
| SubQSubcutaneous | 1 mL | 2-3x weekly | Athletic/performance supportReference report | 4-12 weeks typical program length | 10 |
Population Population not independently verified; see the reference and linked research. Context Reported in Pep-Pedia’s educational protocol table. Study attribution and applicability to this exact product are not independently established. No standardized formula or validated combination timeline; interaction classifications are source claims. Source route wording IM or SubQ Source tabs Injectable | |||||
| IMIntramuscular | 1 mL | 2-3x weekly | Athletic/performance supportReference report | 4-12 weeks typical program length | 10 |
Population Population not independently verified; see the reference and linked research. Context Reported in Pep-Pedia’s educational protocol table. Study attribution and applicability to this exact product are not independently established. No standardized formula or validated combination timeline; interaction classifications are source claims. Source route wording IM or SubQ Source tabs Injectable | |||||
| SubQSubcutaneous | 1 mL | 1-2x weekly | Liver & metabolic healthReference report | 4-12 weeks typical program length | 10 |
Population Population not independently verified; see the reference and linked research. Context Reported in Pep-Pedia’s educational protocol table. Study attribution and applicability to this exact product are not independently established. No standardized formula or validated combination timeline; interaction classifications are source claims. Source route wording IM or SubQ Source tabs Injectable | |||||
| IMIntramuscular | 1 mL | 1-2x weekly | Liver & metabolic healthReference report | 4-12 weeks typical program length | 10 |
Population Population not independently verified; see the reference and linked research. Context Reported in Pep-Pedia’s educational protocol table. Study attribution and applicability to this exact product are not independently established. No standardized formula or validated combination timeline; interaction classifications are source claims. Source route wording IM or SubQ Source tabs Injectable | |||||
No protocols match these filters.
Study and label doses retain their study context. Reference reports are unvalidated practices, not personal treatment instructions. Ranges remain ranges; escalation stages are labeled.
Reported use periods and breaks. These do not establish a safe cycle or prove that breaks prevent tolerance.
Injectable
- Use period
- 4-12 weeks typical program length
- Break
- Breaks not typically required - can be used ongoing
Reported timing
Morning preferred for energy benefits. Some prefer pre-workout timing.
Side effects & safety
Human safety is unresolved
The checked material does not establish a human adverse-event rate or safe self-use regimen for this exact product.
1Variable formulation
Verify actual ingredients; compounded products are not FDA-approved for efficacy.
B6 and other ingredients
Repeated high exposure may cause neuropathy; GI upset, odor, headache or restlessness possible. Liver disease needs review.
Stop symptoms
Allergy, injection infection/fever, numbness, tingling, weakness, severe GI symptoms or unusual fatigue.
Not a complete safety screen. Discuss health decisions with a qualified clinician.
Combinations & interactions
7 entriesCheck cautions and reported pairings. A compatibility claim does not establish that a combination is safe.
Lipo-C
Caution reportedDuplicate MIC/vitamins.10
Reference report · Pep-Pedia label: Monitor CombinationB-complex supplements
Caution reportedExcess B6 exposure.10
Reference report · Pep-Pedia label: Monitor CombinationMAOIs
Caution reportedSource flags psychiatric-medication concerns.10
Reference report · Pep-Pedia label: Use CautionAnticoagulants
Caution reportedSource flags bleeding concerns.10
Reference report · Pep-Pedia label: Monitor CombinationSemaglutide
Unverified pairingClinic practice; combination efficacy unproven.10
Reference report · Pep-Pedia label: CompatibleTirzepatide
Unverified pairingClinic practice; combination safety unproven.10
Reference report · Pep-Pedia label: CompatibleOther medicines and research compounds
Not establishedNo clinical interaction study for the exact proposed combination was verified; absence of evidence does not establish compatibility.1
Research contextNo matching interactions. Try another name or filter.
Reconstitution
A blend name does not specify concentration, ingredients or a diluent. Use the exact product documentation; no universal dilution is established.1
Reference preparation details
Reported handling information, not a validated formulation or instruction to prepare an injectable product.
Injectable
The source describes a premixed injectable blend requiring no reconstitution.
- Form
- Source describes a prepared product
Concentration and storage depend on the actual compounded product.
Appearance & documentation
Appearance and a purity certificate cannot establish sterility, identity, or suitability for injection.
Reported appearanceLicensed Compounding PharmacyReported appearanceClear Ingredient LabelingReported appearanceHealthcare Provider PrescriptionReported variationFormulation VariationsReported variationNo Combination StudiesReported concernUnregulated SourcesReported concernExaggerated Claims
10Available forms
No verified packaging examples included.
Amounts are total blend mass. Formulas and ratios vary. Approved and research products are not interchangeable.
Storage after mixing
Reconstituted research vials
No applicable mixing data
The available sources describe prepared products or do not establish a reconstitution method.10
Full storage notes from Pep-Pedia
10Refrigerate at 2-8°C. Protect from light. Discard if cloudy or discolored.
Storage depends on the formulation, diluent, container, and handling. Follow the specific product label or pharmacist’s instructions.
Research findings
No blend trialsSource context
No standardized formula or validated combination timeline; interaction classifications are source claims.
Compound identity & other names
A marketing name for mixtures of carnitine, lipotropic nutrients and vitamins. Formulas differ, and ingredient studies do not validate a particular combined injection.
Investigational or nonstandard product; no FDA-approved formulation verified for this exact entry.
How it may work
Ingredients participate in fatty-acid transport, liver lipid handling, methylation and energy metabolism; nutrient roles do not prove injectable-blend benefit.10
Ingredient evidence does not test the blend
The listed bibliography concerns individual nutrients, other formulations or broad nutrition research. No controlled study of this exact named injectable combination was identified in the targeted search.
1Research areas and evidence gaps
- No validated combined-product PK, interactions or clinical response timeline.
- Research-market product identity, purity and formulation cannot be established from a publication.
Community reports Unvalidated
Metabolic-support discussions as described by Pep-Pedia.1
No representative survey, independently verified products, or controlled outcomes.
Search coverage and review status
No additional 2025–2026 peer-reviewed efficacy trial of this exact product was identified in this targeted check. Earlier evidence and unresolved listed references are retained.
- Checked
- 2026-10-12
- Search
- "Fat Blaster" lipotropic injection clinical trial 2025 2026
- Catalog
- Pep-Pedia ↗ · 7 listed references retained
- Targeted search, not an exhaustive systematic review.
- Bibliography-only entries are retained for traceability and are not treated as verified findings.
AI-prepared summaries. Independent medical editorial review is pending.
References
Original sources and review status. Open a reference to read its summary.
1Pep-Pedia: Fat Blaster — community referenceCommunity source checked
AI-PREPARED SUMMARY
Accessed October 12, 2026. Secondary descriptions and bibliography; community schedules are unvalidated reports, not recommendations.
Ingredient evidence does not test the blend
The listed bibliography concerns individual nutrients, other formulations or broad nutrition research. No controlled study of this exact named injectable combination was identified in the targeted search.
2L-Carnitine Weight Loss Meta-Analysis (2020)Pep-Pedia report · Primary source not checked
AI-PREPARED SUMMARY
Pep-Pedia reports: The pooled component studies found modest reductions of 1.21 kg in weight and 2.08 kg in fat mass; the injectable blend was not tested.
Reported population / model
37 RCTs
Reported study details
2,292 participants · Overweight/obese · -1.21 kg body weight, -2.08 kg fat mass
Reported by Pep-Pedia; the linked publication, design, doses and result have not been independently verified here.
Read the Pep-Pedia report ↗Pep-Pedia reference card; original summary of its reported findings · Checked 2026-10-12
3Inositol for PCOS - Systematic Review (2023)Pep-Pedia report · Primary source not checked
AI-PREPARED SUMMARY
Pep-Pedia reports: Inositol studies in PCOS reportedly reduced BMI by 0.45 relative to placebo. These component data do not establish Fat Blaster efficacy.
Reported population / model
26 RCTs
Reported study details
1,691 patients · BMI reduction · Improved insulin sensitivity
Reported by Pep-Pedia; the linked publication, design, doses and result have not been independently verified here.
Read the Pep-Pedia report ↗Pep-Pedia reference card; original summary of its reported findings · Checked 2026-10-12
4Vitamin B6 Effects on Obesity - RCT (2021)Pep-Pedia report · Primary source not checked
AI-PREPARED SUMMARY
Pep-Pedia reports: A small oral B6 trial reported body-composition and insulin-sensitivity changes; it did not evaluate the mixed injectable product.
Reported population / model
44 obese women
Reported study details
80mg pyridoxine · 8 weeks · Decreased weight, BMI, fat mass
Reported by Pep-Pedia; the linked publication, design, doses and result have not been independently verified here.
Read the Pep-Pedia report ↗Pep-Pedia reference card; original summary of its reported findings · Checked 2026-10-12
5Choline and Liver Fat Metabolism - ReviewPep-Pedia report · Primary source not checked
AI-PREPARED SUMMARY
Pep-Pedia reports: Choline deficiency can impair hepatic lipid export and cause fatty liver; correcting deficiency is distinct from proving a weight-loss blend works.
Reported population / model
Multiple studies
Reported study details
Human and animal models · Fatty liver development
Reported by Pep-Pedia; the linked publication, design, doses and result have not been independently verified here.
Read the Pep-Pedia report ↗Pep-Pedia reference card; original summary of its reported findings · Checked 2026-10-12
6NADH/NAD+ Supplementation Review (2023)Pep-Pedia report · Primary source not checked
AI-PREPARED SUMMARY
Pep-Pedia reports: The review reports higher blood NAD measures without clear effects on weight, resting energy use or blood pressure.
Reported population / model
Multiple RCTs
Reported study details
NAD+ boosters · No significant weight effects
Reported by Pep-Pedia; the linked publication, design, doses and result have not been independently verified here.
Read the Pep-Pedia report ↗Pep-Pedia reference card; original summary of its reported findings · Checked 2026-10-12
7MIC Lipotropic Injections - Limited Clinical Evidence (2013 Review)Pep-Pedia report · Primary source not checked
AI-PREPARED SUMMARY
Pep-Pedia reports: The source identifies sparse human evidence for combined methionine/inositol/choline injections despite component studies in animals.
Reported population / model
Limited clinical trials
Reported study details
Mixed results · Mostly rodent studies
Reported by Pep-Pedia; the linked publication, design, doses and result have not been independently verified here.
Read the Pep-Pedia report ↗Pep-Pedia reference card; original summary of its reported findings · Checked 2026-10-12
8NAD+ metabolism and its roles in cellular processes during ageingLinked reference · Not independently reviewed
REFERENCE NOTE
Listed in Pep-Pedia’s bibliography; the linked publication and its findings have not been independently verified in this pass.
Pep-Pedia bibliography · Checked 2026-10-12
9Pep-Pedia: Fat Blaster — reported pharmacokineticsReference estimate; not independently verified human PKCommunity source checked
AI-PREPARED SUMMARY
Lists a half-life of 4 hrs and a peak time of 1 hr. Stated attribution: Component peptide data estimates. This value is reported by a secondary reference. The stated attribution has not been independently verified as a route- and formulation-matched human PK measurement. Five half-lives is not complete clearance, and the source’s “cleared” value is not used as a measured endpoint.
Secondary reference page checked; the underlying quantitative claim is not independently confirmed. · Checked 2026-10-12
10Pep-Pedia: Fat Blaster — route-specific referenceReference page checked; underlying claims require separate verification.Community source checked
AI-PREPARED SUMMARY
Source page checked across available routes. Protocols, cycles, storage, mechanisms and pairing claims are secondary reports; checking the page does not independently validate those claims. Original concise summaries are used here.
Content coverage audit · Checked 2026-10-12